StemCell Institute
TSE:7096

Watchlist Manager
StemCell Institute Logo
StemCell Institute
TSE:7096
Watchlist
Price: 793 JPY 1.28% Market Closed
Market Cap: 8.1B JPY

Wall Street
Price Targets

Price Targets Summary
StemCell Institute

There are no price targets for StemCell Institute.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
StemCell Institute Competitors:
Price Targets
HIMS
Hims & Hers Health Inc
39% Upside
EUDA
EUDA Health Holdings Ltd
149% Upside
INNV
InnovAge Holding Corp
38% Upside
LH
Laboratory Corporation of America Holdings
21% Upside
CCRN
Cross Country Healthcare Inc
45% Upside
VIJAYA
Vijaya Diagnostic Centre Ltd
12% Upside
4694
BML Inc
11% Upside
MD
MEDNAX Inc
9% Upside

Revenue
Forecast

Revenue Estimate
StemCell Institute

For the last 6 years the compound annual growth rate for StemCell Institute's revenue is 15%. The projected CAGR for the next 3 years is 17%.

15%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
StemCell Institute

Operating Income forecast
is not available for
StemCell Institute

Net Income
Forecast

Net Income Estimate
StemCell Institute

For the last 6 years the compound annual growth rate for StemCell Institute's net income is 18%. The projected CAGR for the next 3 years is 10%.

18%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is StemCell Institute's stock price target?
Not Available

StemCell Institute doesn't have any price targets made by Wall Street professionals.

What is StemCell Institute's Revenue forecast?
Projected CAGR
17%

For the last 6 years the compound annual growth rate for StemCell Institute's revenue is 15%. The projected CAGR for the next 3 years is 17%.

What is StemCell Institute's Net Income forecast?
Projected CAGR
10%

For the last 6 years the compound annual growth rate for StemCell Institute's net income is 18%. The projected CAGR for the next 3 years is 10%.

Back to Top